Process analytical technologies in the pharmaceutical industry : the FDA's PAT initiative : Process analytical chemistryHINZ, Dirk C.Analytical and bioanalytical chemistry. 2006, Vol 384, Num 5, pp 1036-1042, 7 p.Article

The American Society for Clinical Pharmacology and Therapeutics and the pharmaceutical industryABRAMS, W. B.Clinical pharmacology and therapeutics. 1990, Vol 47, Num 2, pp 282-286, issn 0009-9236Article

Les ambitions d'Ingérop dans l'ingénierie pharmaceutique : Pharmacie = Ingerop's ambitions in pharmaceutical engineeringSAVOSTIANOFF, Dmitri.Info chimie magazine. 2000, Num 423, pp 102-103, issn 1286-0921Article

Industrie pharmaceutique: logistique de distributionGOETZ-LOPES, Virginie.Techniques de l'ingénieur. L'Entreprise industrielle. 2007, Vol AGL1, Num AG5435, issn 1282-9072, AG5435.1-AG5435.18Article

Results from a bench marking survey on cassette dosing practices in the pharmaceutical industryACKERMANN, Bradley L.Journal of the American Society for Mass Spectrometry. 2004, Vol 15, Num 9, pp 1374-1377, issn 1044-0305, 4 p.Article

Logistik und Verfahrenstechnik in der Fabrik 2000 = Logistics and process technology in the factory of the year 2000FINK, M; SIMON, R. W.Pharmazeutische Industrie. 1995, Vol 57, Num 6, pp 507-509, issn 0031-711X, 3 p.Article

Having the last laugh at big pharmaCOOMBES, Rebecca.BMJ. British medical journal (International ed.). 2007, Vol 334, Num 7590, pp 396-397, issn 0959-8146, 2 p.Article

Upping the ante on antibodies : Antibody engineering and manufactureBAKER, Monya.Nature biotechnology. 2005, Vol 23, Num 9, pp 1065-1072, issn 1087-0156, 8 p.Article

Stratégies de diversification dans le secteur biopharmaceutiqueLE, Philippe; HARA, Liuichi; GANESAN, Balaji et al.Biofutur (Puteaux). 2011, Num 326, pp 60-62, issn 0294-3506, 3 p.Article

Ghosts in the Machine: Comment on SismondoMCHENRY, Leemon.Social studies of science. 2009, Vol 39, Num 6, pp 943-947, issn 0306-3127, 5 p.Article

Industrie pharmaceutique: logistique de distribution. ApplicationsGOETZ-LOPES, Virginie.Techniques de l'ingénieur. L'Entreprise industrielle. 2008, Vol AGL1, Num AG5436, issn 1282-9072, AG5436.1-AG5436.10Article

L'échantillonnage dans le contrôle de fabrication des médicamentsKIGER, J.L.LA LETTRE DES NOUVELLES PHARMACEUTIQUES : BULLETIN DE L'ORDRE DES PHARMACIENS. 1981, Num 242, pp 269-384Article

Fortschritte auf dem Gebiet der Arzneimittelentwicklung. XIX = Progrès dans la recherche pharmaceutique. XIX = Progress in the field of drug development XIXDELENK-HEYDENREICH, K; HENKLER, G; KELLER, U et al.Pharmazie. 1986, Vol 41, Num 9, pp 617-626, issn 0031-7144Article

HOW A MARRIAGE WITH BIG PHARMA ENDED IN DIVORCEARIE, Sophie.BMJ (Overseas and retired doctors ed.). 2013, Vol 347, Num 7928, pp 15-16, issn 1759-2151, 2 p.Article

New Product Development with Discrete Event Simulation: Application to Portfolio Management for the Pharmaceutical IndustryPEREZ-ESCOBEDO, J. L; AZZARO-PANTEL, C; PIBOULEAU, L et al.Industrial & engineering chemistry research. 2011, Vol 50, Num 18, pp 10615-10629, issn 0888-5885, 15 p.Article

Tautomer Preference in PDB Complexes and its Impact on Structure-Based Drug DiscoveryMILLETTI, Francesca; VULPETTI, Anna.Journal of chemical information and modeling. 2010, Vol 50, Num 6, pp 1062-1074, issn 1549-9596, 13 p.Article

Was versteht man unter Medical Affairs ? = Qu'entend-on par Medical Affairs ?HAUSLER, Jean-Marc-c.BULLETIN DES MEDECINS SUISSES. 2008, Vol 89, Num 49, pp 2127-2129, issn 1661-5948, 3 p.Article

Germany: dampened expectation for 2002Manufacturing chemist (London. 1981). 2002, Vol 73, Num 7, pp 37-39, issn 0262-4230Article

Active pharmaceutical ingredientsSTOKER, Andy.Chemical engineer (London). 2002, Num 732, pp 38-39, issn 0302-0797Article

Perfect partneringMOSCHO, Alexander; LEITER, Josef.Nature biotechnology. 2001, Vol 19, pp 21-22, issn 1087-0156, SUPArticle

Les mesures réglementaires en faveur des médicaments orphelins aux Etats-Unis et au Japon : une source d'inspiration pour l'EuropeACAR, V; TACCO, F; SARRUT, B et al.Le Pharmacien hospitalier. 1999, Num 136, pp 31-36, issn 0768-9179Article

Médicaments orphelins : L'Europe comble son retard = Orphan drugs : Europe makes its delayLa Revue Prescrire. 1998, Vol 18, Num 190, pp 868-870, issn 0247-7750Article

Buyers guide 97Pharmaceutical technology. 1997, Vol 21, Num 7, issn 0147-8087, 294 p.Serial Issue

Il ruolo del chimico industriale nell'industria farmaceutical = The role of the industrial chemist in the pharmaceuti2cal1 industryMARCHI, E.La Chimica e l'industria (Milano). 1996, Vol 78, Num 4, issn 0009-4315, 392, 445-450 [7 p.]Article

Skilled incompetence in the management of R & DJENSEN, I; JORGENSEN, S; SAPIENZA, A. M et al.Drug development research. 1995, Vol 35, Num 1, pp 1-6, issn 0272-4391Article